Prostate Cancer Trial, Recruiting NCT06398639 Sponsor: Adam S. Kibel, MD Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06398639
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are able to understand the study information and are willing to sign a consent form agreeing to take part.
  • You are expected to live for more than 10 years based on your current health.
  • You have never been diagnosed with prostate cancer.
  • You are between 40 and 69 years old.
  • You have not had a prostate biopsy (a small tissue sample taken for testing) in the last 5 years.
  • You have not had an MRI scan of your prostate in the last 5 years.

Who may not be able to join:

  • You are not willing to sign the consent form agreeing to take part in the study.
  • You have a bleeding or blood clotting problem that cannot be treated or corrected, which would make a biopsy unsafe.
  • You have a serious or uncontrolled health condition, such as an active infection, heart failure, unstable chest pain, an irregular heartbeat, or a mental health or personal situation that would make having a biopsy or surgery unsafe.
  • You are unable to have an MRI scan (for example, due to having certain metal implants or severe claustrophobia) (confirm with trial site).

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Adam S Kibel, MD, MHCM, Brigham and Women's Hospital

Phone: (617) 525-7697

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Adam S. Kibel, MD
Registry
ClinicalTrials.gov
Start date
7 May 2024
Est. completion
30 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Risk Ratio - Three Age Groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov